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Vitamin 0 3 , la,25(OH)203' and its metabolites regulate the 
growth and differentiation of several cell types . Vitamin 0 3 
and its analogue, calcipotriol (MC 903), inhibit the prolifer-
ation of cultured human and mouse keratinocytes and induce 
keratinocyte differentiation. Calcipotriol is effective in the 
treatment of psoriasis in which increased plasminogen acti-
vator activity has been reported. We analyzed therefore the 
effects of calcipotriol and vitamin 0 3 on the production of 
plasminogen activator (PA) activity in human keratinocytes 
and a mouse keratinocyte cell line. Caseinolysis-in-agarose 
assays indicated that vitamin 0 3 decreases total PA activity in 
both keratinocyte culture systems. Zymographic analyses of 
the medium indicated that the secreted activator was of the 
urokinase type (u-PA). A decrease was observed also in extra-
cellular matrix and membrane-associated U-P A activity of 
vitamin 0 3 and calcipotriol treated cells. Immunoblotting 
analysis of the conditioned medium from human keratino-
T he hormonally active form of vitamin D 3 , la,25 (OHhD3 participates in the maintenance of calcium . homeostasis [2) . Besides in bone and intestine, specific vitamin 0 3 receptors arc expressed in the skin, para-thyroid, pituitary, muscle, and the cells of the im-
mune system. Some tumors also express the receptor for vitamin 0 3 
[3). Vitamin 0 3 regulates the growth and differentiation of severa'! 
cell types. Vitamin 0 3 and its new analogues act also as strong 
immunomodulators [4] and inhibitors of malignant cell growth [5], 
which makes them potentially useful in future cancer therapy. 
Vitamin 0 3 is known for is antiproliferative effects, and it has a 
good effect in the treatment of the psoriatic skin. Locally applied 
vitamin 0 3 results in the decrease of inflammation in psoriasis in 
association with decreased scaling and keratinocyte proliferation 
[6]. Vitamin 0 3 analogue, MC 903 (calcipotriol), is a more suitable 
therapeutic agent for the treatment of psoriasis because of its minor 
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cytes revealed a decrease in the u-PA protein levels. Accord-
ingly, Northern hybridization analysis of the respective 
mRNAs indicated a rapid decrease in urokinase mRNA 
levels. Calcipotriol decreased u-PA activity also in the pres-
ence of inducers of u-PA activity like transforming growth 
factor-p, epidermal growth factor, and phorbol-12-myris-
tate-13-acetate. Calcipotriol also caused a decrease in tissue 
type PA (t-PA) activity of the keratinocytes. Most t-PA activ-
ity was associated with the extracellular matrices and cell 
membranes as revealed by zymographic analysis. Paradoxi-
cally, the secretion and deposition to the matrix of plasmino-
gen activator inhibitor type 1 decreased in calcipotriol-
treated cells. The results indicate that a major effect of 
vitamin 0 3 on cultured keratinocytes is a decrease of plas-
minogen activator activity . Key words: pericellular proteoly-
sis/plasminogen activator/plasminogen activator inhibitor-
l/TGFp.] Invest DermatoI101:706-712, 1993 
effects on the regulation of calcium homeostasis [7,8]. The effects of 
vitamin 0 3 on keratinocyte growth and differentiation as well as its 
immunomodulatory functions evidently playa central role in its 
therapeutic effects. Vitamin 0 3 participates in the regulation of the 
differentiation of epidermal keratinocytes. It induces the formation 
of cornified envelope and other changes associated with differentia-
tion [9 - 11]. Induction of transforming growth factor-p (TGFpl 
and TGFpz) is one mechanism by which keratinocyte growth and 
differentiation can be modulated by vitamin 0 3 and calcipotriol [12). 
Enhanced plasminogen activator activity is associated with psori-
asis [13,14] . The present study was carried out to analyze the effects 
of vitamin 0 3 on the major regulator of the proteolytic system of 
cells, the PA system. Two types of plasminogen activators, urokin-
ase (u-PA) and tissue plasminogen activator (t-PA), are responsible 
for the conversion of protease zymogen plasminogen to active plas-
min (see [15]). Plasmin is a wide-spectrum serine protease capable of 
degrading protein constituents of extracellular matrices and base-
ment membranes as well as activating other proteolytic enzymes 
including latent collagenases. t-PA is considered to be mainly in-
volved in thrombolysis, whereas urokinase activity is associated 
with cell migration and tissue destruction. Changes in secreted PA 
activity are associated with changes in cell growth . Rapidly grow-
ing cells secrete often high amounts of u-PA activity whereas rela-
tively low levels are usually detected in quiescent or slowly growing 
cells. Some cytokines enhance extracellular proteolytic activity in-
dependent of the growth state of cells [16). In keratinocytes trans-
forming growth factor-p (TGFP) enllances urokinase-type plas-
minogen activator (u-PA) activity in association with growth 
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. hibition [17}. Urokinase, when bound to its cell surface receptor, 
In efficiently enhance local levels of plasmin (18], which in turn 
f::ds to focal proteolysis and local activation and release of growth 
£ ctors from extracellular storage places. 
aWe report here that vitamin D3 and calcipotriol-treated human 
d murine keratinocytes express decreased levels of secreted as well ~ matrix- and membrane-associated u-PA activity. Growth-inhibi-
ry concentrations of vltamm D J and calClpotnol decreased u-PA 
CO t 'v i ry within 12 h, whereas the maximal effect was around 24 h ac I cc f' . D d" C b 
. cubation. The en ect 0 vltamlll 3 was a Omll1atlllg Leature e-
In se this decrease was detected also in the presence of inducers of ~~~A activity like TGFpl, epidermal growth factor (EGF), .and 
I igh extracellular calcium concentratIOn. USll1g human keratlllo-
1 te cultures we observed a decline in u-PA mRNA and protein 
f:vels by calcipotriol. A notable decrease in U-P A mRNA level was 
detected after 3 h ca!cipotriol treatment. The effect was transient; 
fter 24 h no differences In u-PA mRNA levels were observed. 
~aradoxically, the PAI-l levels of the cultures decreased also during 
h incubation. t-PA was found to be assoCIated mal11ly wIth the 
t x~racellular matrices and the cell membranes, and its activity de-
e ased also during ca!cipotriol treatment. These results suggest that ~~~amin D3 and its analogueca!cipotriol ~re potent regulators of the 
PA system in culcured keratmocytes. ThIS effect may have ;\ benefi-
cial ro le in the treatment of psoriasis and on a number of infl amma-
tory and invasive processes. 
MATERIALS AND METHODS 
R gents la,25(OH), DJ (calcitriol) , and its analogues MC 903 (calcipo-tri~ [19]), EB 1089, KH 1060, and MC 1288 [4] were kind gifts from Leo 
Pharmaceutical Products, Copenhagcn, Denmark. EGF was from Coli abo-
. e Research (Bedford, MA), porcllle TGFpl from R&D Systems (Min-rat~;olis MN), and PMA (phorbol-12-myristatc-13-acetate) from Sigma ~ehemic~l Co. (St Louis, MO) . Radioacti~e reagcnts [J5S]methionine (50 
mCi/ml, > 1000 C i/mmol), L-[S-3H)-prohne (lmC I/ ml, 31,5 C I/ mInol), 
[U_14C]-glycinc (50,uCI/ml, 113mCI/mmol), and [32P]dCTP (10 mCI/ml, 
_ 6000 Ci/mmol) were purchased from Amersham International PIC 
(Amersham, UK). 
Cell cultures Cultures of human epidermal keratinocytes, 10caJ ly estab-
lished from human foreskin biopsies, were cultivated in keratinocyt.c gro.wth 
medium (KGM, C lone tics Corp., San Diego, CAl contallllng bovUle pitUi-
tary extract (BPE, 0.1 %) and low calcium (0.05 mM). BALB/MK-2 mousc 
iderrnal keratinocytes werc obtalllcd from Dr. Stuart Aaronson (NatJOnal 
g'ancer Institute, Bethesda, MD). The cells were cultured in m.edium 199 
taining 0.05 mM Ca++ supplemented With 10% heat-l11actrvated feta l :~ serum (GIBCO), 4 ng/ml EGF, 100 IU/ml penicill in, and 50 ,ug/ ml 
streptomycin. 
When the cultures reached confluency they were washed with and incu-
bated further in serum-free medium for 18 - 24 h prior to vitamin 0 , stimu-
lation to exclude possiblc. 5timul~tioll by other growth modulators from 
seruUl. All experiments were carned out under serum-free COnditIOns. 
Caseinolysis Assays Caseinolysis-in-agarosc assays were carried out as 
described [20]. The caseinolysis gels cOlltained plasminogen (KabiVitrum, 
Stockholm, Sweden) and casein in 1.2% agarose (FMC BioProducts, Rock-
land ME). Plasminogen, when activated by PA present 111 the medIUm 
sam~le, degrades casein and forms a clear zonc of caseinolysis in the gel 
during the sampl: diffusion, proportional to the P A activity of the sample 
and time of diffUSion. Different drlutlons of human 11lgh molecular weight 
urokinase (Calbiochem, La Jolla , CAl were used to draw standard plots 
where PA activity is plotted agail\SC the diameter of the sphere, which 
describes the area of the zone of clearing. There is a logarithmic relationship 
in the caseinolysis assay between the diameter of the lytic sphere and PA 
activity. The PA activity was plotted in international units (IU/ml). 
Zymographic assays were used to identify the molecular forms of tile PAs 
[21]. The medium samples were -" rst subjected to sodium dodccylwlfatc-
polyacrylamide gel electrophoresIs (SDS-PAGE) under non-rcducHlg con-
ditions. SDS was removed by extensive washing (3 X 200 ml , 4 h) with 
2.5% Triton X-100 in phosphate-buffered saline (PBS, 170 mM NaCI, 
10 mM sodium phosphate buffer, pH 7.4). The gels were then placed on 
caseinolysis gels and incubated at 37"C until' lysis zones were observed. The 
positions of PAs in 50S gels were seen as lysis zones in the il1dicator gels. 
Cell Labeling To measure vitamin D)-induced changes in macromole-
cule synthesis , mouse kcratinocytes were treated with calcipotriol for 12, 24, 
and 48 h in the presence of labeled amino acids. Separate experiments were 
carried out using [J5SJ-methionine, L-[5-JHJ-proline, and [U-14Cj-glycine. 
After incubation the conditioned medium was collected and cells or extra-
cellular matrices (prepared as explained below) were lysed in 1 M NaOH. 
Macromolecules were then precipitated from the Iysates with trich loroacetic 
acid (10 % final concentration). The precipitates were washed twice with 
cold acetone and solubilized in 200 mM NaOH, and the incorporated radio-
activity was determined in a liquid scintillation counter. 
Analysis ofP AI-I Protein Upon termination of the vitamin DJ stimula-
tion the conditioned media were collected and clarified by centrifugation. 
PAI-l binds tightly to concanavalin A (ConA) -Sepharose and can be quan-
titatively removed from the medium (see [1 7]). To analyze the vitamin OJ 
induced changes ill the amounts ofPA1-l protein , 1 1111 aliquocs of the media 
were adsorbed with ConA - Sepharose (Pilannacia LKB Biotechnology Inc., 
Uppsala, Sweden) (50 p I 50% [v/v] suspension in PBS). The Sepharose 
particles were thcll washed three times with PBS. The bound proteins were 
dissolved in Laemmli 's gel sample buffer and analyzed by 7% SDS-PAGE 
under reducing conditions. The radioactive molecular weight markers used 
were myosin (M, 200,000), phosphorylase b (M, 92,500), bovine serum 
albumin (M, 69,000), ovalbumin (M, 46,000), carbonic anhydrase (M, 
30,000), and lysozyme (M, 14,300) (Amersham Corp.). 
Immunoblotting Because antibodies against murine u-PA are not avail-
able, we carried oue ill1munoblotting analysis of u-PA from serum-free con-
ditioned medium of human keratinocytes using rabbit polyclonal antibodies 
against human u-PA (Product number 389, American Diagnostica Inc., 
Greenwich, CT). Aliquots of the medium (100 Jil) were analyzed by 7% 
SDS-PAGE under non-reducing conditions. Proteins were transferred at 
100 mA for 20 h onto lmmobilon-P membranes (Milliporc Corporation, 
Bedford, MA) . Nonspecific binding was blocked with 5% non-fat milk in 
PBS/Triton X-IOO (0.5%) and the mcmbranes were incubatcd with anti-
bodies in 0.05 M Tris-HCI buffer, pH 7.4, containing 0.05 M ethy/enedia-
minetetraacetic acid, 0.15 M NaCI, 0.05% Twcen-20. After four washes 
with the same buffer the bound antibodies were detected using peroxidasc-
conjugated avid in sta ining procedure (Dakopatts A/ S, Glostrup, Denmark) 
and enhanced chemiluminescence (ECL) detection system (Amersham 
Corp.). 
Analysis of Melllbrane-Bound PA Activity T o analyze PAs bound to 
cell surface receptors or ce/llayers , vi tamin OJ - treated keratinocytc cultures 
were first washed with 0.2% BSA in PBS. The cells were then trcated with 
50 mM glycine-Hel buffer, pH 3.0, containing 0.1 M NaCl at rOOm tem-
perature for 5 min as described [22J. The buffer was collected and neutral-
ized for analysis of PA activity by zymography. 
Isolation of the Extracellula.r Matrix After collection of the media, the 
cultures were rinsed with PBS. Subsequently, the cultures were extracted 
three times for 5-min periods each time, with 10 mM Tris-H CI buffer, pH 
8.0, comaining 0.5% sodium deoxycholate and 1 mM phenylmethanesulfo-
nyl fluoride in an ice bath (23). After two rapid washes with 2 ]11M Tris-HCI 
buffer, pH 8.0, tbe proteins were extracted with Laemmli's sample buffer 
and analyzed by SDS-PAGE and fluorography. 
RNA Isolation and Northern Hybridization Analyses Confluent 
cultures of human keratinocytes were incubated under serum-free condi-
tions for 8 h and exposed to the vitamins as described above. Total cellular 
RNA was prepa.red by acid guanidinium thiocyanate-phenol-chloroform 
extraction [24J and CsCI-gradient centrifugation [25J. RNA was quantified 
by absorbance measurement at 260 11m. 
For Northern hybridization atlalysis 10 ILg of RNA was fractionated on 
1.2% agarose ge ls containing 2.2 M formaldehyde. Gels were transferred to 
nirroccllulose membranes and prehybridization and hybridization were per-
formed as described [26]. Membranes werC hybridized to cDNA probe spe-
cific to human u-PA. A cDNA probe specific for glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) was used as a control for the amounts of 
RNA. The cDNA probes were laheled with (32PjdCTP using the nick trans-
lation DNA labeling system (Amers/Jaln Corp.) . The relative radioactivity 
was estimated from fluorograms by laser scanning densitometry. 
RESULTS 
Vitamin OJ and Calcipotriol Decrease the Proteolytic Activ-
ity Secreted by Mouse Keratinocytes To analyze the secreted 
plasminogen activator (PA) activity from mouse keratinocytes the 
m edium samples from cultures treated w ith increasing concentra-
tions of vitamin D 3 or calcipotriol (Me 903) were collected and 
ana lyzed by zymography . The major PA was identified as urokinase 
plasminogen activator (u-PA) on the basis of molecular mobility on 
SDS-PAGE (M, 50,000) (see [27]) co mpared to the mobility of 
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Figure 1. Effect of calcipotriol on plasminogen activator activity of mouse 
keratinocytes. A) Dose dependence. The cells were incubated with increas-
in g concentrations of calcipotriol (MC 903) under serum-free conditions for 
24 h. The media were then collected and analyzed by SDS-PAGE followed 
by zymography. Lysis zones ofM, 50,000 corresponding to the mouse u-PA 
and M, 90,000 corresponding to the size of u-PA' PAI-1 complex (pia ill 
arrolll) are shown. Ctrl, untreated control. B) Time dependence. Measure-
ment of total plasminogen activator activity by caseinolysis-in-agarose assay. 
Mouse keratinocytes were treated with 10- 8 M calcipotriol for indicated 
times. The medium samples were then collected and analyzed. The values 
are plotted as international units (IU Iml) using a serial dilution of human 
urokinase standard. C) Zymographic analysis of urokinase activity of sam-
plesofthe experiment in B. The area ofM, 50,000 urokinase (u-PA) bands of 
the zymogram is shown. Calcipotriol treatment is indicated by (+). Time 
points are 6, 12,24, and 48 hrs. 
human urokinase standard. A clear decrease in the amount of u-PA 
activity was observed when 10- 8 M or higher concentrations of 
vitamin D3 or calcipotriol were used (Fig lA) . Growth inhibition of 
these cells by vitamin D3 is achieved with similar concentrations 
(maximal inhibition with lO-a M vitamin D3 (121). The amount of 
PA activity at M, 90,000, corresponding to the size of u-PA' PAI-I 
complex was also decreased. Lower-molecular-weight lysis zones 
near the complex were also observed. These bands probably repre-
sent degradation products of the complex, and they were not char-
acterized further. In cells treated with 10- 6 M calcipotriol, PA ac-
tivity was barely detectable, which might be a toxic effect of high 
concentrations of vitamin D3. Slightly rol,!nded cells were observed 
at the termination of the incubation although the cells were viable 
and attached to the dishes. In addition, a decrease of total protein 
synthesis was observed at 10-6 M calcipotriol (data not shown). 
Differences between the responses of the keratinocytes to calci-
potriol or vitamin D3 were not observed. In the following we de-
scribe the results obtained using calcipotriol. 
To study the time course of the regulation of u-PA activity, the 
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keratinocytes were treated with 10- 8 M calcipotriol for increasing 
periods of time, after which the total P A activity of the medium 
samples was analyzed by the caseinolysis assay. A clear decrease in 
total PA activity was observed (Fig 1B). Inspection of the time 
course showed a clear effect after 12 h; maximal effect was observed 
around 24 h incubation. At this point about 50% decrease of PA 
activity was detected in calcipotriol-treated cells by caseinolysis 
assays. At 48 h a decrease in the total PA activity of control cells was 
observed, possibly reflecting formation of inactive complexes. Zy-
mographic analysis of the time course for Mr 50,000 u-PA band 
indicated that the decrease was even more prominent and rapid. An 
incubation of 12 h was enough to induce a maximal effect, which 
was estimated to be a more than fiv efold difference in u-PA activity 
(Fig le). This rapid decrease in the activity is reflected more slowly 
in the total PA activity as observed in Fig 1B, probably due to the 
presence of P A-inhibitors in the medium, although their amount 
also changes in response to calcipotriol (see below). 
Effect of Calcipotriol on Macromolecule Synthesis To 
evaluate the relevance of the decrease of u-PA activity, we analyzed 
the effects of calcipotriol on newly synthesized total secreted pro-
teins by labeling the cells with three different radioactive amino 
acids in individual experiments (see Materials and Methods). We fol-
lowed the secretion of radio labeled proteins into the medium and. 
matrices of mouse keratinocytes during a 48-h incubation. Analysis 
of the time profiles of secreted proteins by radioactivity determina-
tions indicted only a moderate decrease (5 -10%) in the production 
of secreted macromolecules in calcipotriol treated cells. This sug-
gests that the observed decrease in u-PA activity is not due to a 
general decrease in protein synthesis. High extracellular calcium 
(1.2 mM), another inducer of differentiation of keratinocytes, de-
creased the secretion of synthesized proteins by 25% (data nor 
shown). The rise in extracellular calcium induces epidermal differ-
entiation markers more rapidly than calcipotriol [28]' A decrease in 
the deposition of radiolabeled macromolecules into the extracellu-
lar matrices was also observed. The effect was most prominent after 
24 h where 30% decrease was detected, whereas at 6 and 48 h the 
decrease was about 10%. Analysis of the radiolabeled matrix prepa-
rations by SDS-PAGE was in agreement with the trichloroacetic 
acid precipitation results (data not shown). 
Calcipotriol also Decreases PAI-l Secretion Regulation of 
pericellular proteolysis involves also specific inhibitors of PA activ-
ity. PA inhibitor type 1, PAl-I, is produced by keratinocytes and it 
inhibits the activity of both U-P A and t-P A. It is readily induced by 
TGFp (16], which is regulated by vitamin D3 (12]. Analysis of the 
conditioned medium from calcipotriol-treated mouse keratinocytes 
by ConA-Sepharose chromatography (see Materials and Methods) 
and SDS-PAGE analysis indicated a time-dependent decrease in the 
secretion ofPAI-1 (Fig 2A) . An effect was observed within 6 h, and 
after 12 h incubation PAI-1 levels were notably decreased in calci-
potriol-treated cells. After 24 h its amount was about half of that in 
the control as determined by scanning of the fluorogram (Fig 2A). A 
decrease of matrix-associated PAI-1 was also observed as judged by 
inspection of the fluorograms of gels (Fig 2B) and this was more 
prominent than general decrease of matrix protein accumulation 
(see above). This can result from decreased synthesis or from the 
general decrease of matrix protein accumulation resulting ill les 
available association sites for PAl-I. These results indicate that cal-
cipotriol can regulate the synthesis and activity of several constitu-
ents of the P A system. 
Analysis of the P A Activity of Extracellular Matrix 
Preparations Because certain structures under the cells, namely, 
the footpads or cell attachment sites are the centers of PA activity 
[29] and because u-PA can associate with the pericellular matrix, W~ 
analyzed next the PA activity of the murine keratinocyte extracellu-
lar matrices isolated by sodium deoxycholate extraction (see Materi- I 
a/s and Methods). Caseinolysis assays indicated about 50% decrease in 
the PA activity in matrix preparations frol11 cells treated with calci-
potriol for 24 h. We next analyzed by zymography the molecular 
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Figure 2. Effect of calcipotriol on PAI-l secretion and deposition to the 
matrix. Mouse keratinocytes were labeled with [3sSJ-methionine in the pres-
ence (+) or absence (- ) of calcipotriol (10-8 M) for times indicated. Samples 
were analyzed by SOS-PAGE followed by fluorography. A) Medium sam-
ples were analyzed by (ConA) -Sepharose chromatography. The radioactiv-
iry was estimated from a fluorogram of shorter exposure using laser scanning 
densitometry. The values of the chart are expressed as relative values. B) 
Extracellular matrices were prepared by deoxycholate extraction. Relevant 
parr of the fluorogram is shown. The M, 48,000 band shown was identified 
as PAI-l also by immunoblotting (see [17]). 
forms of PAs associated with the matrices. Inspection of the zymo-
grams revealed zones of activity at the M, 50,000 and Me 70,000 
areas corresponding to the mobilities of u-PA and t-PA respectively 
(see [27)). The amount of t-PA activity in matrix preparations was 
significantly higher than the amount of u-PA activity. In addition to 
these, an M, 110,000 lysis zone corresponding to the t-P A . PAI-1 
complex was seen (Fig 3, lalles a-d). Comparison of the zymogra-
phic profiles of the matrices indicated that the extracellular matrix-
associated PA activity was also decreased by calcipotriol. 
When zymograms were made from keratinocyte matrices pre-
pared after mild acid treatment of the cells, which dissociates u-PA 
from the cell surface receptors, a notable decrease in PA activity was 
observed (Fig 3, lanes C, d) . This suggests that acid treatment releases 
not only receptor- or membrane-associated but also matrix-asso-
ciated PA activity and complexed forms. 
Analysis of Acid-Removable Cell-Associated P A Activity 
Urokinase has been found in many cases to be cell-surface asso-
ciated. It is bound to a specific u-PA receptor with high affinity and 
shows slow internalization [22]. To analyze the possible role of 
u-PA receptor in the regulation of PA .activity in mouse keratino-
cytes we washed calcipotriol treated cells with mild acid to remove 
receptor-bound PAs (see above), and analyzed the PA contents of 
the supernatant fluids by zymography. This treatment appears to 
affect the matrix-associated PAs and PA' PAI-l complexes as well 
(Fig 3, lanes a-d). Inspection of the zymograms indicated that the 
a b c d e f 
Me 903: + + + 
~t-PA 
~u-PA 
matrices acid-eluates 
Figure 3. Effect of calcipotriol on membrane- and matrix-associated PA 
acti~iry. Mouse keratinocytes were incubated with (+) or without (-) calci-
potnol (10-8 M) for 24 h. Conditioned medium was then removed, and 
cells were washed and incubated with mild acid buffer to release cell-surface 
associated PA activiry (see Materials alld Methods) . The acid eluate was col-
lected, neutralized and analyzed by zymography (eJ). Extracellular matrices 
were prep~red by deoxycholate extraction after removal of the medium (a, b) 
or after aCid elutIOn of the cells (c,d) . The matrices in (c,d) were prepared 
after the aCid eluates (e,f) were collected. Lysis zones of M, 50,000 and 
70,000 corresponding mouse u-PA and t-PA and M, 110,000 corresponding 
the size of t-PA· PAI-l complex (plaill arrow) are indicated. 
majority of released P A activity was of t-PA type (Fig 3, lanes eJ). 
Accordlllgly, It was found that the amount of cell-associated (acid-
removable) P A activity was decreased in calci potriol-treated cells. In 
addition, it was found that t-PA activity was released from mouse 
keratinocytes as well, suggesting that the majority of secreted t-PA 
activity in cultured keratinocytes remains either membrane or ex-
tracellular matrix bound. 
Effects of Calcipotriol on the Urokinase Plasminogen 
Activator Activity and mRNA Levels in Human Kera-
tinocytes Because ~itamin D3 and calcipotriol were potent regu-
lators of PA actiVity III mouse keratinocytes and antibodies against 
munne u-PA are not available, we wanted to confirm the results in 
primary human epidermal keratinocytes and confirm by immuno-
blotting the identity of the Me 50,000 protein. Analysis by zymo-
graphy of the medium samples indicated that calcipotriol decreases 
u-PA activity also in human keratinocytes in a time-dependent 
manner (Fig 4A). Earlier time points, analyzed in a separate experi-
ment, were comparable to those shown of murine cells (Fig 1). The 
decrease of u-PA activi ty was also dose dependent at the same con-
centration range as in the murine cells (data not shown). In zymo-
graphy no ~ther ly~is zone~ were detected during the selected zy-
mography lllcubation penod. However, prolonged incubation 
resulted in a profile resembling the situation in Fig 1A with the 
exception that the differences between the u-PA bands were no 
longer clear. Immunoblotting analysis for u-PA indicated that the 
decrease in u-PA activity correlated to a decrease in protein levels 
(Fig 4B). About four- to eightfold decrease was observed at 12 h, 
based on estimation by scanning of the fluorogram, which is in 
agreement with the activity data. An increase in the immunoreac-
tive band corresponding to the M, 90,000 u-PA'PAI-l complex 
was observed in the medium of calcipotriol-treated cultures indicat-
ing a small increase in complex formation. 
Northern hybridization analysis of isolated mRNAs revealed a 
notable decrease of urokinase mRNA level within 3 h in calcipo-
triol-treated cells (Fig 4C). In agreement with the increase of u-PA 
activity during prolonged incubation the decrease of urokinase 
mRNA level was barely detectable after 24 h. 
Regulation ofPA Activity by Vitamin D3 Analogues Many 
different vitamin D3 analogues have been synthesized by now. 
Using assays described above we did not find any differences be-
tween the regulation of PA activity by vitamin D3 or calcipotriol. 
We analyzed next the effects of three analogues of vitamin D3 on 
the secretion ofPA activity by mOllse keratillocytes. The concentra-
67 -
-+ u-PA 
43 -
c. 
3h 24h 
MC 903: + + 
+u-PA 
Figure 4. Calcipotriol regulation of u-PA expression in human keratino-
cytes. Cultured human epidermal keratinocytes were treated with (+) or 
without (- ) calcipotriol (10- 8 M) for indicated times under serum free 
conditions. A) Zymographic analysis of the medium. Aliquots (20 ILl) were 
analyzed by casein overlay zymography. The u-PA band comigrating with 
the human u-PA marker is shown. Note that the decrease of u-PA activity 
ca n still be observed at 48 h. B) Immunoblotting analysis of the medium 
proteins. Aliquots of the conditioned medium (100 ILl) were separated in an 
8% SOS-PAGE and analyzed by immunoblotting using polyclonal antibod-
ies against human u-PA. Bound antibodies were detected by enhanced 
chemiluminescence detection system. The mobilities of molecular weight 
markers, u-PA and M, 90,000 u-PA · PAI-1 complex (plailJ arrow) are indi-
cated. C) Northern hybridization analysis of u-PA gene expression. Kerati-
nocytes were incubated with calcipotriol as indicated. After termination of 
the incubation total cellular RNA was prepared and analyzed by Northern 
hybridization using the u-PA cONA probe. Control analysis for constant 
GAPOH gene indicated that the amounts of RNA were comparable (not 
shown) . 
tions that we used here induce growth inhibition in U 937 lym-
phoma cell s and in normal lymphocytes [4] . The growth of mouse 
keratinocytes was also inhibited by these analo gues (data not 
shown). EB 1089 (10- 11 M), K.H 1060 (10- 13 M), and M C 1288 
(10- 12 M) all decreased the secretion of PA activiry as judged by 
caseino lys is-in-agarose assays (data not sllown), indicating that this 
is a genera l feature in the action of vitamin D3 and its analogues. 
Calcipotriol Prevents PA Induction by TGFpl, EGF, High 
Extracellular Calcium, and PMA We have previously found 
that TGFp enh ances urokinase and PAl-l secretion in human and 
murine keratinocytes [17]. Calcipotrio l-treated keratinocytes se-
crete active TGFp [12). W e therefore originally expected to see a 
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TGFp-mediated increase in PA ac tivity in calcipotriol-treated cells, 
but as demonstrated here P A activity decreases in response to calci-
potriol. 
The combined effects of calcipotriol and TGFp on the secretion 
of PA activiry were analyzed by zymography. As described earlier, 
TGFp induced PA activity in keratinocytes. When both calcipotriol 
(10- 8 M) and TGFpl (1 ng/ml) were added to the medium of the 
keratinocytes a decrease in P A activity, similar to the effect of calci-
potriol alone was observed (Fi g SA). Preincubation of keratinocytes 
with TGFp1 for 3 h before the addition of calcipo triol did not alter 
the response of calcipotrio l inhibition of PA activiry, suggesting 
that vitamin D3 and its derivatives are very potent inhibitors of 
urokinase expression, even in the presence ofTGFP1. As expected, 
enhanced amounts of u-PA . PAI-l complexes were seen in the me-
dium from TGFpl-treated ce lls (Fig SA). 
Epidermal growth factor (EGF) is needed for the growth of the 
mouse keratinocyte cell line and it also enhances its u-PA activiry. 
However, calcipotriol was able to downregulate EGF-induced u-PA 
A. 
MC903: -
TGFp1: -
B. 
~ (3 
cv 
~ 
:::s 
S: 
CJ I 
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10-8 
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+ MC 903 
-10 -9 
10-9 [M] 
+ 
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[log (M)] 
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Figure 5. Effects of calcipotriol on PMA, calcium and cytokine induction 
of u-PA activity in murine keratinocyte cultures. The keratinocytes were 
treated with these known inducers of u-PA activity together with calcipo-
triol under serum-free conditions as indicated for 24 h. Medium samples 
were then collected and analyzed for PA activity by zymography. A) Com-
bined effects ofTGFp1 and calcipotriol. Cel ls were n eated with cakipotriol 
and TGFp1 (1 ng/ml) as indicated. T he u-PA band and M, 90,000 comple-x 
corresponding to the size of the u-PA · PAI-1 complex are indicated. Nore 
that calcipotriol (10- 8 M) decreases the secretion of u-PA also in the pres-
ence of TGFP1. Enhancement of complex formation in samples from 
TGFp-treated cells results from induction of PAI-1 [15]. B) Combined 
effects with some other modulators. Cells were treated with EGF (4 ng/ml), 
PMA (3 nM), or high calcium (1.2 mM) in the presence of increasing con-
centrations of calcipotriol. The first lalle is the control of the indicated exper-
iment. The secolld lalle indicates treatment with the respective u-PA inducer 
only. In all cases calcipotriol (10- 8 _10- 7 M) decreased u-PA activity more 
than 50%. 
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activity (Fig 5B). To analyze the effect of calcipotriol on the en-
hancement of u-PA activity induced by high extracellular calcium 
(1.2 mM) or the phorbol ester PMA (3 mM), calcipotriol was added 
to the cells together with these agents. High calcium and PMA 
alone enhanced the secretion of u-PA activity in the cultures, but 
calcipotriol prevented the induction also in these cases at 10-7 -
10-8 M concentrations (Fig 5B). 
DISCUSSION 
The present work indicates that vitamin D3 and its analogues de-
crease the extracellular proteolytic activity of cultured keratinocytes 
in a time- and dose-dependent manner. The effect was transient 
suggesting that calcipotriol does not induce irreversible effects on 
the P A system of cultured keratinocytes. This is based on the fol-
lowing observations. 1) Caseinolysis-in-agarose assays revealed de-
creased amounts of secreted PA activity in the medium of mouse and 
human keratinocytes cultivated in the presence of vitamin D 3 • 2) 
Zymographic analyses indicated ~hat the. secret~on of M, 50,000 
u-P A activity from both cell types mto their medIUm was decreased 
by vitamin D3· 3) In mouse keratinocytes vitamin D3 was observed 
to dovvnregulate u-PA activity also in the presence ofTGFp, EGF, 
high calcium, and PMA, whic:h all indu~e u-PA activity .. 4) In 
human keratinocytes a decrease m the secretion of u-PA protem was 
observed in association with a rapid decrease of u-PA mRNA. 5) 
Analysis of the extracellular matrix and membrane-associated PAs 
of the mouse keratinocytes indicated that M, 70,000 t-PA activity is 
expressed in the cells, and that its activity is decreased by vitamin D3 
as well. In addition, t-PA' PAI-1 complexes (M, 110,000) were 
detected in the matrices but not in the medium. Paradoxically, the 
secretion of PAl-1 into the medium was also decreased by vita-
min D 3 · 
Human keratinocytes are capable of changing vitamin D3 precur-
sor to the hormonally active form and this local event seems to be 
regulated during keratinocyte differentiation [30]. Vitamin D3 has 
been suggested to stimulate the terminal step of differentiation by 
acting on cells of the spinous and granular layers of epidermis. 
Expression of TGFp is found in these cell layers in vivo. We have 
recently observed secretion of biologically active TGFp1 and 
TGFp2 in cultured keratinocytes treated with vitamin D3 [12], 
which could explain a number of its effects in the skin. Because 
TGFP1 enhances the PA activity of cultured keratinocytes [17] we 
analyzed here the interrelationship~ between TGFp induction and 
the regulation of PA actiVity by vltamm D3 • When TGFp1 was 
added to the medium of mouse keratinocytes together with vitamin 
D the TGFp-induced enhancement ofPA activity was prevented. 
This suggests that the effect of vitamin D3 in the regulation of PA 
activity in keratinocytes is not dependent on TGFp synthesis, be-
cause although vitamin D3 induces the secretion of biologically 
active TGFp [12] it decreases the secretion of u-PA activity. 
TGFp1 enhances the secretion of u-PA into the medium of cul-
tured murine and human keratinocytes [17]. It is a potent regulator 
of the proteolytic activity of cultured cells, and it is associated with 
the pericellular matrices. Proteolytic release of matrix-associated 
modulators of proteolytic activity [31] form regulatory chains of 
events that may participate in inhibitory feed-back systems in the 
pericellular space [32]. . . 
High extracellular calcIUm and the tumor promotor PMA II1duce 
differentiation associated changes in epidermal keratinocytes. Like 
vitamin D3 they have been found to induce TGFp activity or 
ruRNA in cultured keratinocytes in association with differentiation 
[33,34]. It has been suggested that u-PA functions as an early re-
sponse gene in growth regulation [35]. Grimaldi et al [35] have 
found that after prolonged incubation with calcium u-PA mRNA 
decreases in mouse keratinocytes in association with differentiation 
and cessation of proliferation. This decrease is probably not due to 
the direct effect of calcium, but is rather a cellular differentiation 
response [35]. Th~ short-term effects of calcium and PMA on PA 
activity seem to differ from the actton of vltam1l1 D3 , because they 
enhance u-PA activiry in cultured keratinocytes [16]. Although all 
these agents can induce keratinocyte growth inhibition and differ-
entiation the mode of action seems to be different and this is proba-
bly also reflected in the regulation of u-P A mRN A. A rapid decrease 
in u-PA mRNA and protein levels by vitamin D3 suggests that 
regulation ofPA activiry is an early response in vitamin D3 - induced 
growth inhibition and differentiation. 
Elevated levels of cell-associated PA activiry are associated with 
more differentiated phenotype in mouse keratinocytes [36], and 
proteolytic events presumably facilitate terminal differentiative 
events o~ n~clear dissolution and squame detachment. The t-PA/ 
u-PA ratIO mcreases with keratinocyte differentiation and t-P A ac-
tivity is present. in the superficial layers of epidermis [37] . Also 
munn.e epld.e~m.ls undergoing wound repair may eXl?ress t-PA ac-
tiVIty 111 addition to an enhancement in u-PA activity [38] . Psoriatic 
plaques ex~ress enhanced levels of t-PA activity, which may be a 
charactensttc of damaged epidennis [13,14]. In calcium-induced 
keratinocyte differentiation u-PA localization changes towards 
cell-cel! borders~ which suggests that u-P A may participate in the 
regulatIOn of epidermal adhesion [39]. In epithelial cells u-PA se-
cretion seems to b~ polarized so that the secretion is either apical or 
basolateral dependll1g on cell type and this is another mechanism to 
control localized proteolysis [40]. The ability of vitamin D3 to 
downregulate the P A system in cultured keratinocytes and also in 
fibroblastic cells (our unpublished observation) and to induce the 
expression and secre.tion of biologically active TGFp suggests that 
th~se two events ~re m~portant alterations in the healing of psoriatic 
leSIOns and assOCIated lllflammation, and possibly in the inhibition 
of malignant growth. 
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